ACAD vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 31, 2026

ACAD

54.1
AI Score
VS
PCRX Wins

PCRX

59.2
AI Score

Investment Advisor Scores

ACAD

54score
Recommendation
HOLD

PCRX

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ACAD PCRX Winner
Forward P/E 47.619 9.1075 PCRX
PEG Ratio 50.8642 11.2121 PCRX
Revenue Growth 9.4% 5.1% ACAD
Earnings Growth 86.2% -88.4% ACAD
Tradestie Score 54.1/100 59.2/100 PCRX
Profit Margin 36.5% 1.0% ACAD
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.